Metataxonomic and Immunological Analysis of Feces from Children with or without Phelan-McDermid Syndrome
Loading...
Official URL
Full text at PDC
Publication date
2024
Advisors (or tutors)
Editors
Journal Title
Journal ISSN
Volume Title
Publisher
MDPI
Citation
Alba, C., Herranz, C., Monroy, M. A., Aragón, A., Jurado, R., Díaz-Regañón, D., Sánchez, C., Tolín, M., Miranda, C., Gómez-Taylor, B., Sempere, F., Álvarez-Calatayud, G., & Rodríguez, J. M. (2024). Metataxonomic and Immunological Analysis of Feces from Children with or without Phelan-McDermid Syndrome. Microorganisms, 12(10), 2006. https://doi.org/10.3390/microorganisms12102006
Abstract
Phelan–McDermid syndrome (PMS) is a neurodevelopmental disorder characterized by a developmental delay and autism spectrum disorder (ASD)-like behaviors. Emerging research
suggests a link between gut microbiota and neuropsychiatric conditions, including PMS. This study aimed to investigate the fecal microbiota and immune profiles of children with PMS compared
to healthy controls. Fecal samples were collected from children diagnosed with PMS and age matched healthy controls. The bacterial composition was analyzed using 16S rRNA gene sequencing,
while short-chain fatty acids (SCFAs) were quantified through gas chromatography. Immunological profiling was conducted using a multiplex cytokine assay. Significant differences were observed in
the gut microbiota composition between PMS patients and controls, including a lower abundance of key bacterial genera such as Faecalibacterium and Agathobacter in PMS patients. SCFA levels were also
reduced in PMS patients. Immunological analysis revealed higher levels of several pro-inflammatory cytokines in the PMS group, although these differences were not statistically significant. The findings
indicate that children with PMS have distinct gut microbiota and SCFA profiles, which may contribute to the gastrointestinal and neurodevelopmental symptoms observed in this syndrome. These results
suggest potential avenues for microbiota-targeted therapies in PMS.
Description
Author Contributions:
Conceptualization, J.M.R.; writing—original draft preparation, C.A., C.H., M.A.M., J.M.R., A.A., R.J., D.D.-R., C.S., M.T., C.M., B.G.-T., F.S. and G.Á.-C.; data analysis, C.A.
and C.H.; sample analysis, C.H., A.A., R.J. and D.D.-R.; patient management and demographic data collection, M.A.M., C.S., M.T., C.M., B.G.-T., F.S. and G.Á.-C. All authors have read and agreed to the
published version of the manuscript.
Funding:
This research was funded by the resources of the Spanish PMS Association (Asociación Síndrome Phelan-McDermid; Boadilla del Monte, Madrid, Spain) and by Complutense University of
Madrid, grant UCM920080
Data Availability Statement:
The 16S rRNA gene sequences analyzed in this study are available in the NCBI repository under the accession code PRJNA1155863. Further inquiries can be directed to
the corresponding authors